SOPHiA GENETICS has unveiled the world’s first capture-based myeloid clinical solution to receive the CE-IVD mark. The standardized molecular diagnostic application represents a breakthrough in diagnostics for hematological diseases.
Data is at the heart of applicable genomics. As the volume and depth of genomic data grows, bioinformaticians are translating the data into interpretable patterns leading to new biological insight.
“I’d Like to See Our Understanding of at Least One More Disease Transformed by Genomics and Big Data” – Jeremy Grushcow
Combining over 15 years’ experience with pharma and life sciences businesses with a passion for participant-centric research, Jeremy Grushcow is CBO at Sequence Bio, where he saw a once-in-in a lifetime opportunity to change how we treat, prevent and understand disease.
Google’s DeepMind has potentially made the first significant application of Artificial Intelligence (A.I.) in healthcare, after developing AI to diagnose disease by analysing medical images.
Storing data in DNA is a lot easier than getting it back out, but a team of researchers has designed a system that could solve all these problems.
We attended ‘The Great Genome Sequencing Debate’ earlier this week, chaired by Vivienne Parry from Genomics England, to discuss the future of genomic testing.
To help you plan your visit, or perhaps inspire you to sign up for your free place, we’ve put together a handy guide to this year’s theme, and some of our top picks from the agenda.
Paul focuses on the possibilities for big data in biomedicine, using computationally intensive approaches, including deep learning and graph databases.
SOPHiA GENETICS announced at the Precision Medicine World Conference (PMWC) in Silicon Valley that its artificial intelligence, SOPHiA, has gained radiomics capabilities.
What’s blockchain technology, how, and why was it developed, and why is everyone talking about it? Alex Schmid provides us with an overview of challenges blockchain technology can help solve within life sciences, and what about it, that makes it so suitable.
We bring genomics to the UK in our latest issue, as we look ahead to what this year’s Festival of Genomics London has to offer.
At ASHG, we spoke to Gavin Stone, Vice President of Marketing at Edico Genome, to discuss their World Record achievement in more detail, as well as the advantages offered by their DRAGEN tool.